These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antigenic cross-reactivity between human leukemic cells and dinitrophenylated normal leukocytes.
    Author: Madyastha PR, Madyastha KR, Barth RF.
    Journal: Exp Hematol; 1983 May; 11(5):371-81. PubMed ID: 6406255.
    Abstract:
    Dinitrofluorobenzene-modified normal human leukocytes (DNP-LK) have been shown to evoke the production of antibodies, which following absorption with erythrocytes and unmodified leukocytes (UN-LK) had residual leukoagglutinating activity against human leukemic cells (HLC). In the present study we observed that rabbit antisera prepared against cell membrane extracts of DNP-modified granulocytes (DNP-GM) or lymphocytes (DNP-LM) were cytotoxic to HLC. By passive hemagglutination, these antisera were specifically reactive with DNP-GM or DNP-LM conjugated to sheep erythrocytes (SRBC) but not with DNP-modified bovine serum albumin (DNP-BSA) or bovine gamma globulin (DNP-BGG) nor with UN-LK, suggesting that the antisera were devoid of anti-DNP antibodies. Rabbit anti-DNP-BSA or anti-DNP-BGG failed to react with DNP-LK, and anti-DNP antibodies in these sera could not be absorbed by DNP-LK, suggesting that DNP groups either were not expressed on the surface of DNP-LK or were not detectable by these methods. These data, together with our recent finding that dinitrophenylation alters the expression of histocompatibility antigens, suggest that neoantigens cross-reactive with HLC antigens are induced by DNP modification of membrane antigens of normal leukocytes, and that the antibodies produced against these DNP-modified cells are directed mainly against the modified protein and not against the DNP moiety per se.
    [Abstract] [Full Text] [Related] [New Search]